Clinical Trial Update: A Study of Olaparib With Concomitant Radiotherapy in Locally Advanced/Unresectable Soft-tissue Sarcoma [Phase 1]

View source ↗

Summary

Phase 1 study of olaparib with concomitant radiotherapy in locally advanced or unresectable soft-tissue sarcoma has been completed and results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Soft Tissue Sarcoma

Drugs mentioned

• Lynparza (olaparib)

Snippet

Sponsor: Institut Bergonié | Conditions: Soft-tissue Sarcoma | Phase 1 | Status: COMPLETED | Results posted: 2026-02-25